Auctus Capital Partners Advises Sempera Organics, Secures Senior Debt Financing

Secured Senior Debt Financing From

Sempera Organics

Auctus Capital Partners is pleased to announce that it acted as exclusive financial advisor to Sempera Organics, Inc. (“Sempera Organics” or the “Company”), a California-based, vertically integrated researcher, grower, and manufacturer of standardized organic mushroom extracts, on its successful completion of a senior debt financing provided by Newtek Bank. The financing supports the Company’s capacity expansion and continued growth across the rapidly expanding functional ingredients market.

 

Founded in 2020 and headquartered on the West Coast, Sempera Organics produces fungi-derived organic functional ingredients for the beverage industry and the broader health, wellness, and food markets. The Company’s U.S.-grown and processed products are differentiated by non-GMO and third-party lab verification, clinical validation, and trademarked formulations, enabling brands to command premium pricing. Operating from a vertically integrated, zero-waste lab farm in Silicon Valley, California, Sempera Organics delivers certified standardized organic mushroom ingredients at scale with guaranteed quality, faster lead times, and DNA-based, lot-level identity verification.

 

Demand for functional, food-as-medicine ingredients continues to accelerate, with adaptogenic mushrooms increasingly valued for their benefits to immunity, mood, cognition, and overall wellness. Against this backdrop, Sempera Organics has scaled production capacity more than tenfold in just 18 months, yet continued to operate below the demand reflected in existing purchase orders, including a multi-year supply contract with a leading beverage company. To fund facility expansion and meet committed demand, the Company engaged Auctus Capital Partners to identify and secure a tailored debt financing solution.

 

Auctus structured and led a targeted debt advisory process, engaging a focused group of senior lenders to identify a financing partner aligned with the Company’s growth trajectory and capital needs. The resulting senior debt facility from Newtek Bank provides Sempera Organics with the capital to expand manufacturing capacity, support sales and market development, and continue investing in its clinically validated product pipeline.

 

“We were proud to advise Sempera Organics on this financing,” said John Dilatush, Senior Managing Partner at Auctus Capital Partners. “Sempera has built a differentiated, vertically integrated platform and a clinically validated product portfolio that position it exceptionally well to capture growing demand for premium functional ingredients. We are pleased to have secured a financing partner in Newtek Bank that supports the Company’s next phase of capacity-driven growth.”

 

Auctus Capital Partners served as exclusive financial advisor to Sempera Organics, with the transaction led by Auctus’ debt advisory team.

 

About Auctus Capital Partners

 

Auctus Capital Partners is a leading investment banking and financial advisory firm focused exclusively on serving lower middle-market companies. The firm specializes in mergers and acquisitions, private placements of debt and equity, growth capital raises, financial restructuring, valuation, and strategic advisory services. With deep sector expertise and extensive relationships across institutional investors, private equity firms, family offices, and lenders, Auctus delivers customized capital solutions designed to maximize shareholder value and support long-term growth.

 

About Sempera Organics

 

Sempera Organics is a California-based, vertically integrated researcher, grower, and manufacturer of standardized organic mushroom extracts and functional ingredients. Operating a zero-waste, high-tech lab farm in Silicon Valley, the Company produces non-GMO, certified organic, clinically validated mushroom powders and proprietary blends for the functional beverage, nutraceutical, cosmeceutical, and broader health and wellness markets. Sempera Organics differentiates through standardized quality, DNA-based identity verification, faster delivery times, and a growing portfolio of trademarked, evidence-based products.